Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,282,150
+$975,288 QoQ
Shares Held
46,466
+1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#211
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $143,988,175 across 14 Drug Manufacturers - General names. NVS ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
212,013 | $53,844,941 | |
| 2 | ABBV |
AbbVie Inc.
|
162,450 | $40,878,917 | |
| 3 | MRK |
Merck & Co., Inc.
|
106,435 | $13,676,897 | |
| 4 | LLY |
ELI LILLY & Co
|
8,529 | $10,229,939 | |
| 5 | AMGN |
Amgen Inc
|
22,744 | $8,236,057 | |
| 6 | NVS |
Novartis AG
This page
|
46,466 | $7,282,150 | |
| 7 | PFE |
Pfizer Inc
|
158,728 | $3,822,169 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
49,346 | $2,843,316 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,282,150 | 46,466 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $6,306,862 | 45,745 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $5,865,569 | 45,739 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $5,633,982 | 46,558 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $5,227,965 | 46,896 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $4,667,765 | 47,968 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,562,941 | 48,365 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $5,182,259 | 48,678 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $4,765,596 | 49,267 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,461,359 | 44,185 | Shares | Sole | 2024-03-08 | |
| 2023-09-30 | $5,391,856 | 52,934 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $5,964,385 | 59,106 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,684,220 | 61,785 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $5,660,292 | 62,393 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,009,058 | 65,900 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $5,681,007 | 67,207 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,030,881 | 68,728 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $6,085,287 | 69,570 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $5,934,610 | 72,568 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $6,757,233 | 74,060 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $6,363,216 | 74,441 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $7,768,472 | 82,267 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $7,326,466 | 84,251 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $7,587,225 | 86,870 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $9,026,708 | 109,481 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||